drugset / Trial / NCT00257725

Long-Duration Stimulant Treatment Study of ADHD in Young Children

NCT00257725 ↗

Phase 4 Completed 11 enrolled New York State Psychiatric Institute
NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate if Ritalin LA™ is safe and effective for ADHD treatment in 4-to-5-year olds.

Timeline

Start
2005-03
Primary completion
2008-03
Completion
2008-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 20 mg —